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ABSTRACT 
THE EFFECT OF DIFFERENT INTERFACES ON AEROSOL DELIVERY IN SIMULATED 
SPONTANEOUSLY BREATHING ADULT WITH TRACHEOSTOMY 
By 
Alaa Bugis, BSRC 
Background: The delivery of an aerosol via a tracheostomy tube has been previously described 
with both a tracheostomy collar and a T-piece, but not with a Wright mask, or aerosol mask. The primary 
purpose of this study was to quantify lung doses using different interfaces: tracheostomy collar, Wright 
mask, and aerosol mask. The secondary purposes were to compare albuterol delivery between an opened 
vs. a closed fenestration hole and also to determine the effect of inspiratory time:expiratory time (I:E) 
ratio on aerosol delivery. 
Methods: A teaching mannequin (Medical Plastic Labs, Gatesville, TX) with a tracheostomy 
opening was used. Two of the mannequin's bronchi were connected to a "Y" adaptor, which was attached 
to a collecting filter (Respirgard 
™
 II 303, Vital Signs, Englewood, CO), which was connected to a 
breathing simulator (Harvard Apparatus Dual Phase Control Respirator Pump, Holliston, MA) through a 
corrugated tube. Settings for spontaneous breathing were respiratory rate 20/min, and tidal volume 400 
mL. The I:E ratios were adjusted in the first and second comparisons at 2:1 and 1:2, respectively. The 
nebulizer was operated by a flow meter (Timemeter, St. Louis, MO) at 8 L/min with 100% oxygen. In 
every condition, the flow was discontinued at the end of nebulization. The nebulizer was attached to the 
tracheostomy collar (AirLife
™
, Cardinal Health, McGaw Park, IL) in the first group, the Wright mask 
(Wright Solutions LLC, Marathon, FL) in the second group, and the aerosol mask (AirLife
™
, Cardinal 
Health, McGaw, IL) in the third group. Drug was eluted from the filter and analyzed by 
spectrophotometry (276 nm).  
Data Analysis: Paired t-test, one-way analysis of variance (ANOVA), repeated measures 
ANOVA, post-hoc and pairwise comparisons were performed at the significance level of .05, using 
PASW version 18.0.  
 Results: Aerosol delivery was greater with the tracheostomy collar than the Wright mask and 
aerosol mask (p < .05). Closing the fenestration hole increased aerosol deposition significantly at 2:1 ratio 
(p = .04) compared to opening the fenestration at 1:2 ratio. I:E ratio and aerosol delivery were directly 
related. Increasing I:E ratio from 1:2 to 2:1 improved aerosol delivery significantly with tracheostomy 
collar-fenestration opened (p = .009), Wright mask (p = .02) and aerosol mask (p = .01). 
 Conclusion: This study indicates that the use of a tracheostomy collar is the best method of 
delivering aerosol therapy among the three interfaces. The I:E ratio of 2:1 caused greater aerosol 
deposition than 1:2 ratio. The aerosol deposition was better when the fenestration hole was closed 
compared with opened fenestration. 
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CHAPTER I 
INTRODUCTION 
 In the United States, 16,000,000 people have chronic obstructive pulmonary disease 
(COPD). Every year, there are 120,000 deaths from COPD, making it the fourth highest cause of 
death (Johnson, 2007). Patients with acute or chronic respiratory failure are usually patients who 
have COPD or asthma. Those patients may require prolonged respiratory care and mechanical 
ventilation through endotracheal tubes (ETTs) or tracheostomy tubes. Tracheostomy is usually 
suggested if intubation is planned to last longer than several weeks. In a patient requiring more 
than 14 days of ventilatory support, a tracheostomy procedure is recommended within the first 2 
days of intubation. It has been stated that if a tracheostomy performed in the first 2 days rather 
than after Day 14, it will markedly reduce the number of ventilator and intensive care unit days, 
and decrease both the incidence of pneumonia and overall mortality (Pierson, 2005). 
 There are many potential benefits of tracheostomy use such as the ability to 
communicate, the possibility for oral feeding, safe nursing care, and improving a patient's 
comfort. In addition, using tracheostomy tubes will result in lesser need for sedation and lower 
resistance, compared to endotracheal intubation. In turn, this will lead to a shorter hospital stay in 
the intensive care unit and will facilitate a more successful recovery. It has been speculated that 
the use of tracheostomies might decrease ventilator-associated pneumonia by preventing micro 
aspiration of secretions, help in the weaning process by reducing dead space and airway 
resistance, and improve secretion clearance (Durbin, Perkins, & Moores, 2010). The improved 
secretion clearance with the use of tracheostomy tubes helps in making patients more 
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comfortable, requiring less sedation, and reducing the likelihood of aspiration through enhanced 
glottic function.
 
 
 The treatment of asthma patients includes the use of inhaled long-acting β-agonists and 
corticosteroids. The treatment of COPD patients includes the use of inhaled long-acting 
anticholinergic and long-acting β-agonists, which are available in dry powder aerosol form and 
created for oral deep inhalation. However, the delivery devices for long-acting β-agonists and 
long-acting anticholinergics are not designed for patients with artificial airways. A gas-powered 
jet nebulizer is commonly used to deliver aerosol medications. The aerosol reaches patients’ 
airways through a mouthpiece or an aerosol mask. In a review by Hess (2000) it was stated that 
there was no significant difference in clinical response has been found between the mouthpiece 
and the aerosol mask. Moreover, delivering albuterol medication via tracheostomy tube is 
affected by humidification, bias gas flow, and interface. One study conducted by Piccuito and 
Hess (2005) concluded that the use of a T-piece resulted in more albuterol delivery as compared 
to a tracheostomy collar (p = .001). Moreover, the most effective delivery involved the nebulizer 
attached to the tracheostomy tube without additional gas flow (p < .001).  
A Wright mask has been recently developed for humidification purposes for patients with 
tracheostomies. It consists of both a tracheostomy collar and an aerosol mask. No published 
articles on the Wright mask have been found in a literature search. However, in the web site on 
the Wright mask (www.wrighttrachsolutions.com/Abstracts) there is an abstract by Carvalho et 
al. (2010) that evaluated the efficacy and feasibility of the Wright mask. The abstract concluded 
that there are no large differences noted in blood oxygen saturation, comfort, ease of use, or ease 
of breathing in patients with tracheostomies used the Wright mask compared to both the 
tracheostomy collar and the aerosol mask. 
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The Importance of the Study  
 This study is important because the tracheostomy tube has not been very well studied. No 
studies have been found regarding aerosol delivery with tracheostomy collar, Wright mask, and 
aerosol mask all together. It is important to examine the Wright mask because it may be used 
with patients even though its use has not yet been studied. Also, the effect of I:E ratio and 
fenestration hole on aerosol delivery need to be investigated in order to provide guidance to 
clinicians on how to administer aerosol therapy. 
Study Purposes  
 The delivery of aerosol therapy via a tracheostomy tube has been described with both a 
tracheostomy collar and a T-piece (Piccuito & Hess, 2005), but not a Wright mask or an aerosol 
mask. The primary purpose of this study was to quantify lung dose using different interfaces: 
tracheostomy collar, Wright mask, and aerosol mask. The secondary purpose was to compare 
albuterol delivery between an opened vs. a closed fenestration hole and also to determine the 
effect of inspiratory time to expiratory time (I:E) ratio on aerosol delivery. 
Research Questions  
 Upon review of the literature, three important research questions arose:  
1. What is the amount of albuterol delivered to the lungs with different interfaces 
using an open fenestration hole of the tracheostomy tube? 
2. How much albuterol is delivered using a tracheostomy collar, while the 
fenestration hole is opened and closed?  
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3. What is the effect of I:E ratio on aerosol delivery in simulated spontaneously 
breathing adults with tracheostomy? 
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CHAPTER II 
REVIEW OF LITERATURE 
 A literature review was performed using terms related to aerosol therapy through 
tracheostomy tubes. The I:E ratio was also searched. The databases used were Medline, PubMed, 
Science Direct, and Web of Science through both the Georgia State University and the 
Northeastern University libraries. From an exhaustive search, the research questions were 
formulated to investigate how aerosol administration changes through interfaces when I:E ratio 
and fenestration hole are manipulated. 
Tracheostomy 
Epstein (2005) indicated that the trachea was used as an easy entryway to the airways at 
the bedside. It provided an inlet for urgent airway cannulation in the case of acute upper airway 
obstruction. In addition, it provided an inlet for chronic airway access after laryngeal surgery. 
Tracheostomy tubes, in general, were used to allow the discontinuation of ETTs. Most of the 
studies indicated that the tracheostomy tube reduced both airflow resistance and work of 
breathing when compared to ETTs. Tracheostomy tubes differ from ETTs because they have a 
portable inner cannula that can be easily removed for cleaning. In addition, the tracheostomy 
tube has a fenestration hole that can be closed to provide proper mechanical ventilatory support. 
Tracheostomy tubes have important benefits in improving weaning success. 
 Pierson (2005) reported in a review paper that using tracheostomy tubes might facilitate 
weaning from ventilatory support. There were many reasons mentioned why tracheostomy tubes 
can improve the weaning process: (1) A tracheostomy tube can decrease airway resistance; (2) it 
reduces the extrathoracic dead space; (3) it enhances clearance of secretions from patients’ 
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airways; (4) it decreases need for sedation; (5) it lowers the risk of aspiration; and (6) it also 
decreases the work of breathing compared to a translaryngeal ETT with the same internal 
diameter. The difference in dead space between a tracheostomy tube and an ETT is very low. 
However, the literature reviewed from laboratory experiments, short-term physiologic studies on 
clinically stable patients, and evidence from clinical trials indicates that airway resistance and 
anatomic dead space are reduced with tracheostomy tubes. The researcher reported that one 
clinical trial showed that there was no benefit to early tracheotomy. He also reported that in a 
recent clinical trial, investigators found that percutaneous dilational tracheotomy performed in 
the first 2 days of ventilatory support dramatically (1) reduced ventilator and intensive care unit 
days; (2) lowered the incidence of pneumonia; and (3) decreased mortality rate, when compared 
with tracheostomy performed after the Day 14. Tracheotomy tubes helped liberating patients 
from ventilatory support. However, clinician bias as well as physiologic effects may affect this 
conclusion. 
Adoga and Ma'an (2010) investigated the indications and outcomes of pediatric 
tracheostomy in pediatric patients in a Nigerian teaching hospital. In addition, they wanted to 
know if there was a change in the trend of the environment compared to other centers. 
Historically, the most common indication for use of tracheostomy in children was acute 
inflammatory airway obstruction. Nowadays, the most common indication to use tracheostomy 
in children is prolonged intubation. The study was a retrospective chart review of 46 patients. 
There were 29 males and 17 females with ages ranging from 2 months to 15 years. All the 46 
patients had their tracheostomy procedures done between January 2000 and December 2008 and 
were presented to their otorhinolaryngological facility. Most of the patients who had a 
tracheostomy (69.6%) were of ages ranging from 6 to 10 years old. Forty tracheostomies (87%) 
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were performed as emergencies while six (13%) were performed as elective procedures. The 
most common indication for tracheostomy was upper airway obstruction (n = 29, 63%) such as 
respiratory papilloma (n = 20). All the cases employed transverse skin incision. There were no 
intra-operative complications recorded. However, the postoperative complication rate was 
15.2%. The duration of tracheostomy ranged from 5 days to 3 months. All patients were 
successfully decannulated. There were eight mortalities (17%). However, there was no 
tracheostomy-related mortality. Researchers concluded that there is no increase in the incidence 
of tracheostomy in patients less than 1 year of age. The percentage of tracheostomy procedures 
performed on patients aged less than 5 years old was 21.7%. The group that had the fewest 
tracheostomy procedures was within the age range of 11 to 15 years and the percentage was 
8.7%. Their conclusion was that pediatric tracheostomy is safe when performed in a tertiary 
hospital setting.  
Spontaneous Breathing and Tracheostomy 
 O'Callaghan et al. (1989) presented a case report of 2 ½-year-old girl with a tracheostomy 
who was diagnosed with asthma disease. Investigators tested a modified volumatic spacer device 
to deliver beclomethasone diproprionate, ipratropium bromide, and salbutamol aerosols to the 
child. A volumatic spacer device was prescribed into which both bronchodilator and prophylactic 
agents could be activated. The inhalation port of the volumatic spacer was modified by a series 
of tubes, connected with the tracheostomy tube, giving an airtight seal. On inhalation, the valve 
in the spacer device opened, allowing the aerosol to be inhaled. On expiration, the valve closed 
and air was dispelled though small holes near the inhalation port. The spacer device resulted in a 
dramatic improvement in symptoms, and marked reduction in the time spent inhaling the drugs. 
The advantages of this modified spacer device were several; (1) The modified spacer is easy to 
 8 
use; (2) time required for taking therapy decreased from several hours to 15–20 minutes per dose 
daily; (3) the tracheostomy tube needed to be changed less frequently, from every day to weekly; 
and (4) the modified spacer had the ability to administer adequate doses of inhaled steroids and 
bronchodilators to improve asthma control.  
Meeker and Stelmach (1992) reported that the spacer device helped ensure consistent 
delivery of medications to the bronchial tree. They also indicated that it minimizes the 
oropharyngeal deposition of pressurized metered dose inhaler (pMDI) medication. Inhaled 
corticosteroid is available only in pMDI form. Inhaling corticosteroids by a spacer can minimize 
its side effects. However, patients with artificial airways such AirIon and Jackson tracheostomy 
tubes, and patients with hand limitations such as patients with severe arthritis, hand weakness, 
and those with very small hands may be unable to successfully activate the inhaler. Meeker and 
Stelmach described several modifications to help this population receive their aerosol therapy 
effectively. They adapted spacer devices that required few simple modifications of the standard 
pMDI spacer to use them in a patient with a tracheostomy. They used standard Shiley, Portex, or 
Communitrach 15-mm adaptors, and Kamen-Wilkens on tracheostomy tube. The Aero Chamber 
with a mask or InspirEase Bag consisted of soft pliable silicone that easily conformed to the 
patient's neck. The technique of using this spacer was to apply gentle pressure by placing one 
hand on the mask at the stoma site while the other hand activates the pMDI. It was also adapted 
to fit an indwelling tracheostomy tube. The researchers mentioned that patients with hand 
limitations may benefit from the use of an arthritic aid (VentEase, Glaxo) which can be inserted 
into an Aero Chamber thereby allowing the use of a spacer device in this population. This Aero 
Chamber with mask simplified the delivery of pMDI medications in patients with an open stoma. 
 9 
Subhedar et al. (1999) reported a study of four cases of infants with chronic lung disease 
(CLD). Those patients had tracheostomy procedures because of subglottic stenosis. The 
tracheostomy was performed due to the degree of upper airway compromise, which resulted in a 
failure of extubation. The other reason for performing a tracheostomy was due to further 
narrowing that occurred with a concurrent infection of the upper respiratory tract. The purpose of 
their report was to highlight the feasibility of delivering supplemental oxygen and the 
administration of inhaled medications in such patients. Three of the patients received 
supplemental oxygen. The oxygen therapy was administered via a nasal cannula attached to open 
tracheostomy tube and stabilized by taping the tubing to each side of the back of patient’s neck. 
Two of the patients received nebulized bronchodilators. The nebulizer was held over the 
tracheostomy tube opening, and patients were breathing normally. All four patients received 
bronchodilator therapy, and two received inhaled steroids. Aerosol inhalers administered via 
aerosol spacer device were directly attached to the tracheostomy tube. This report did not 
mention information about the deposition of aerosol medications. However, it indicates the 
importance of giving advice to patients on how to administer aerosol therapy. As we studied the 
effect of I:E ratio on aerosol therapy, we will give advice to patients on how to inhale aerosol 
therapy for better outcomes. The researchers concluded that therapists and parents who provided 
inhaled therapy and supplemental oxygen to children with CLD who have tracheostomy should 
be advised and trained of administering such therapy before discharge from a hospital. 
 Piccuito and Hess (2005) investigated whether albuterol delivery through a tracheostomy 
tube is affected by the type of patient interface (T-piece vs. mask), aerosol delivery method 
(pMDI vs. nebulizer), humidification of the inspired gas, and bias flow. A dual-chambered lung 
model was used to stimulate a patient's spontaneous breathing with a lift bar placed between the 
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chambers. The settings they used were a respiratory rate of 20 breaths/min, tidal volume of 400 
mL, and I:E ratio of 1:2. A cuffed tracheostomy tube with an inner diameter of 8 mm was placed 
through a semicircular model that simulated a patient's neck. In the aerosol nebulizer 
experiments, four combinations of humidification and gas flow were used as follows: (1) Heated 
humidity generated using a Concha-Therm. The oxygen outlet flow was around 30 L/min. The 
heat of the humidifier was set to provide a gas temperature at the proximal airway of 
approximately 30 °C with relative humidity greater than 95%; (2) heated aerosol generated using 
a heater and nebulizer. A flow meter was adjusted to power oxygen gas flow of approximately 
30 L/min. The gas temperature measured at the proximal tracheostomy tube was about 30 °C and 
the relative humidity was greater than 95%; (3) high flow without additional humidification 
(around 30 L/min); and (4) a tracheostomy tube without additional flow that was attached to a 
nebulizer. The aerosol nebulizer device was filled with 4 mL of 2.5 mg albuterol medication, and 
operated at a flow rate of 8 L/min. The nebulizer was tested with a tracheostomy collar and a T-
piece. An aerosol spacer device was used for the pMDI experiments and actuation of the inhaler 
(100 µg/ actuation) was synchronized with inhalation. Four actuations were delivered separated 
by more than 15 seconds. A T-piece valve was used with a one-way valve attached either distally 
or close to the aerosol spacer device without the use of additional flow. A filter was placed 
between the distal end of the tracheostomy tube and the lung model. The filter was washed to 
measure the amount of albuterol detected by ultraviolet spectrophotometer. The most efficient 
aerosol delivery method was with the use of the pMDI with a T-piece valve and attachment of a 
one-way valve placed in the proximal position (p < .001). In the nebulizer experiments, the most 
efficient delivery method was with no flow other than to power the nebulizer with a T-piece (p < 
.001). This study had five major findings: (1) there was a delivered amount of albuterol aerosol 
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through a tracheostomy tube with the use of a nebulizer and also with the use of a pMDI; (2) it 
was inefficient to deliver albuterol using high gas flow with the nebulizer; (3) the T-piece was 
more efficient in delivering albuterol than the tracheostomy mask; (4) the pMDI with valved 
holding chamber was more efficient than the nebulizer; and (5) the pMDI was more efficient 
when a T-piece was placed close to the spacer device than when placed in the distal position. 
They concluded that albuterol delivery through the tracheostomy tube was affected by the 
patient's interface, delivery method, and bias gas flow. 
 Lin et al. (2007) measured the albuterol delivery of a jet nebulizer in three different 
pediatric face masks and at three different distances from the face. There were three face masks 
included a standard pediatric face mask, a proprietary pediatric face mask shaped to resemble a 
dragon face, and a proprietary pediatric face mask shaped to resemble a fish face. Researchers 
used an infant mannequin face connected to a lung simulator to stimulate a spontaneously 
breathing patient. The inhaled aerosol mass was measured with the face masks at distances of 0 
cm where the face mask placed directly to the model at 1 cm and 2 cm. For every experiment, 
the nebulizer cup was filled with 3 mL of albuterol sulfate and generated by a flow of 8 L/min of 
oxygen gas. A 5-minute nebulization time was set for each test. They measured inhaled mass by 
collecting the aerosol on a 2-way anesthesia filter that was attached to the back of the 
mannequin’s oral opening via a 15-mm silicon adapter. They also measured the remaining 
amount of drug left in the nebulizer cup and estimated the wasted drug lost to the atmosphere. 
The mean inhaled values of the nominal dose percentage at 0 cm, 1 cm, and 2 cm were as 
follows: In the standard face mask, 2.18 %, 1.45 %, and .92 %, respectively. In the dragon face 
mask, 2.65 %, 1.7 %, and 1.3 %, respectively. In the fish face mask, 3.67 %, 2.92 %, and 2.26 %, 
respectively. Statistically, among the three face mask experiments there was a significant 
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difference in delivering aerosol between the 0 cm and 2 cm distance (p < .001). The highest 
inhaled mass of albuterol significance was for the fish face mask (p < .001) among all three 
distances. When the mask was further separated from the face, the inhaled mass was significantly 
reduced. The study concluded that the face mask design affected the inhaled mass delivered in 
pediatric patients. 
Johnson (2007) studied aerosolized drugs delivered through a tracheostomy tube. He 
recruited 23 patients in his study. The study assessed the clinical ease vs. the clinical difficulty of 
aerosol delivery. He designed interface to connect an Aerolizer and a HandiHaler to a 
trachestomy tube. The study indicated that aerosol therapies were readily delivered to all 
patients. Nineteen of the 23 patients (83%) were able to take the treatment on their own. A bag-
assist was successfully used in the four patients who were unable to take the treatment 
effectively on their own. Johnson also indicated that the aerosol delivery time was less than 3 
minutes. It was concluded that aerosol therapy can be easily delivered through a tracheostomy 
tube if the proper interface is used. 
Keck et al. (2008) compared inhalation with molecular water (vaporizing humidifier) and 
particulate water (trachea spray) in patients with tracheostomies who were breathing 
spontaneously. In their study, they used a randomized two-way crossover study design and a 
prospective, comparative, nonblinded study. They measured the temperature and tracheal 
humidity before and after the use of the tracheal spray and the vaporizing humidifier for 1 week. 
They found that after both spray and inhalation, tracheal temperature and total water content 
increased significantly. The temperature gradient between tracheal air and ambient was 
significantly higher after spray compared to after inhalation. The water gradient after spray and 
inhalation increased nonsignificantly. The water gradient after spray or inhalation did not differ 
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significantly. The study concluded that molecular water was not superior to particulate water 
because humidity and temperature increased after both forms of water delivery. A tracheal spray 
may offer additional benefits in postoperative tracheostomy care for its ease of use, portability, 
and moisturizing effect. 
Mechanical Ventilation and Tracheostomy 
 Fuller et al. (1994) performed a study to compare aerosol administrations in ventilated 
patients. The researchers used four different devices: (1) a 167 mL cylindrical chamber 10.5 × 
4.5 cm; (2) a 700 mL cylindrical chamber 11 × 9 cm; (3) a non-chamber device that allowed 
pMDI attachment to the inspiratory line of the ventilator circuit; and (4) a non-chamber device 
that allowed pMDI attachment directly into the ETT or tracheostomy tube. For their study, they 
recruited 48 patients who were mechanically ventilated. Subjects were given four puffs of 
fenoterol labeled with technetium 99m pertechnetate via a metered-dose inhaler. At the bedside, 
a portable gamma camera was used to identify images of the thorax. The study showed that the 
deposition of radioactivity in the lungs was 5.53 ± .72, 6.33 ± 1.16, 1.67 ± .43, and 3.89 ± .52 
percent for devices (1), (2), (3), and (4), respectively. The researchers did not specify whether 
these data were obtained with ETTs or tracheostomy tubes. There was a statistically significant 
difference in delivery only between devices (1) and (3) and between devices (2) and (3) (p = 
.004). In addition, they found a statistically significant difference between inhalation from both 
chamber devices and the inline non-chamber device, but not between inhalation of other devices. 
The study concluded that a non-chamber device significantly provided smaller amounts of 
aerosol from the pMDI to the lung than a chamber device in the inspiratory ventilator line 
similarly positioned. 
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O'Riordan et al. (1994) characterized factors that may affect aerosol delivery such as 
nebulizer device, drug volume, humidity, and ventilator settings. The researchers also 
characterized technical factors that may affect deposition loads such as radio-labeled compounds. 
They designed a study to evaluate nebulized aerosol delivery to ventilated patients in optimal 
situations. Seven patients were recrutied for this study.  All patients were mechanically 
ventilated through a tracheostomy tube. The humidifier was not operated. For aerosol 
experiments, researchers used a saline solution labeled with 99mTechnetium bound to human 
serum albumin 99mTc-HSA. They administered it via a jet nebulizer that was joined into the 
ventilator circuit. The flow was discontinued at the end of nebulization. A mass balance/filter 
method was used to calculate the inhaled and deposited radioactivity. A gamma camera scanner 
was used to verify the distribution areas of the deposited radioactivity before and after the 
tracheostomy tube removal. The measured radioactivity at each site was expressed in a 
percentage of nebulizer charge. The results showed that the ventilated patients inhaled an 
average of 30.6 %. In addition, the mean deposition in the tracheostomy tube during inspiration 
was 2.6 %.  
Palmer et al. (1998) conducted a study to determine whether aerosolized antibiotics can 
be delivered effectively to the lower respiratory tract in mechanically ventilated patients and to 
identify possible clinical reactions to these agents. Six patients were recruited with tracheostomy 
tubes. The patients received nine doses of nebulized therapy of gentamicin (80 mg) or amikacin 
(400 mg) every eight hours for 14 to 21 days. The researchers measured the doses to the lung 
using antibiotic concentrations and radio-labeled aerosols in airway secretions. The response was 
assessed by (1) changes in the volume of airway secretions, (2) effect on bacterial cultures, and 
(3) changes in the inflammatory cells and mediators of inflammation of the airway secretions. 
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The study concluded that inhaling nebulized aminoglycoside was efficient. Therefore, 
aerosolized antibiotics can make a significant impact on airway secretions. 
Shorten et al. (2000) conducted a study to determine the effectiveness and safety of 
salbutamol delivered via a metered dose inhaler to intubated rabbits. The research was performed 
on five groups of rabbits. The first three groups had tracheal intubation through a tracheostomy 
and received five puffs of 99mTcO4 salbutamol. Group (1) inhaled the drug at elbow connector. 
Group (2) inhaled the drug through a catheter with its distal tip placed at the midpoint. Group (3) 
inhaled the drug at the bevel of the ETT. Rabbits in Group (4) were not exposed to any 
interactions. Group (5) had tracheal intubation through the mouth and received five puffs of 
salbutamol inhaled at the bevel of the ETT. Delivery efficiency was expressed as the ratio of 
radioactivity from the trachea and lungs to the total radioactivity of the delivered dose. 
Histopathologic injury scores were assigned to each lung specimen or trachea. Results showed 
that the delivery efficiency was 30 times greater with the full catheter in Groups (3) and (5) than 
the elbow in Group (1). The study concluded that the increased efficiency acquired by the 
administration of metered dose salbutamol at the distal tip of the ETT was not necessarily related 
with increased epithelial injury. 
Smaldone (2004) reported that antibiotic drugs in the form of aerosols were very useful in 
intensive care. A human model was created of trachea-bronchitis in intubated patients. The 
model provided daily specimens of respiratory secretions, allowing serial investigations of 
airway inflammation and testing of different therapy modes. The local infection was determined 
by a unique method of measured sputum specimen. Laboratory models were invented to explain 
the factors that restrict aerosol delivery to intubated patients. Those models facilitated clinical 
experiments that determined the possible indications for targeted aerosol treatment to patients at 
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risk for lower respiratory disease. It was found that when inhaling antibiotic drugs via nebulizers, 
the drug levels in pulmonary secretions exceed by several doses when compared to the levels 
expected with intravenous administrations. 
Dhand (2004) reported that among aerosol devices such as nebulizers, dry powder 
inhalers, and metered-dose inhalers, only nebulizers and metered-dose inhalers are typically used 
for aerosol delivery to patients on mechanical ventilators. Previously, the artificial airway and 
ventilator circuit were thought to be serious obstacles to deliver aerosols effectively to patients 
on mechanical ventilators. In the past decade, in vivo and in vitro investigations assisted good 
understanding of the complex array of factors that affected inhaled drug delivery in mechanically 
ventilated patients. Many investigators have shown that, with careful attention to aerosol delivery 
technique, the effectiveness in patients on mechanical ventilators is proportional to that in 
ambulatory patients. 
Inspiratory to Expiratory (I:E) Ratio 
 Few references discussed the I:E ratio. For that reason the following articles are reviewed 
although they are not strongly related to this study. 
 Boros (1979) studied the relationship of I:E ratio to optimum oxygenation and 
ventilation. Twelve neonates who had severe lung disease were recruited. Subjects were 
mechanically ventilated with volume-preset infant ventilators using different I:E ratios and 
different airway pressure waves. The ventilator settings of fraction of inspired oxygen (FIO2), 
tidal volume (Vt), respiratory rate , and positive end expiratory pressure (PEEP) remained 
constant. The I:E ratios were increased by reducing inspiratory flow rate or holding the 
inspiratory time. For each I:E ratio and pressure wave combination, the researcher measured and 
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compared the mean airway pressure (MAP), peak inspiratory pressure (PIP), hydrogen ion 
concentration (pH), partial pressure of oxygen in arterial blood (PaO2), partial pressure of carbon 
dioxide in arterial blood (PaCO2), and blood pressure. The study indicated that there was a direct 
relationship between oxygenation and mean airway pressure. The mean airway pressure can 
change with any change in I:E ratio, PEEP, or airway pressure wave. The study concluded that 
an I:E ratio and pressure wave combination helped optimize oxygenation, ventilation, and mean 
airway pressure.  
Stewart et al. (1981) assessed the effects of changing ventilator parameters on blood 
gases, intracranial pressure (ICP), and MAP. Researchers recruited 20 neonates with respiratory 
failure which required mechanical ventilation. The study involved random changes in I:E ratio, 
PEEP, and PIP. The MAP, PaO2, ICP, and end-tidal PCO2 were observed continuously. The 
study showed a significant relationship between MAP and PaO2. The mean change in PaO2/MAP 
was 4.92 torr. The change of PaO2/MAP was highest for changes in PEEP (p < .001), followed 
by PIP (p < .001), and I:E ratio (p < .05), respectively. The association between changes in PIP 
and PEEP vs. PaCO2 and PH was significant. Decreases in PIP and increases in PEEP resulted in 
an increase in PaCO2 and a reduction in pH. In addition, increases in PIP and decreases in PEEP 
resulted in a reduction in PaCO2 and an increase in pH. There was no significant association 
between ICP and MAP. However, there was a significant relationship between changed ICP and 
PaCO2 during changes in PIP (p < .001). This study concluded that increases in PEEP led to 
elevations in PaO2 per change in MAP, followed by elevations in PIP and I:E ratio. 
Lim et al. (1999) investigated whether extending the I:E ratio of the mechanical ventilator 
would decrease the heterogeneity of regional ventilation and enhance gas exchange to a greater 
degree than in gas ventilation (GV). Researchers inducted 18 rabbits with acute lung injury by 
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saline solution lavage. Three I:E ratios were used in gas ventilation and then in partial liquid 
ventilation (PLV). I:E ratios were changed either by modifying pause (1:2, 1:1, and 2:1; Group 
1) or by modifying inspiratory flow rate (1:3, 1:1, and 2:1; Group 2). With increasing I:E ratio in 
all subjects, PaCO2 decreased significantly (74 mmHg, 66 mmHg, and 66 mm Hg; p = .006), 
PaO2 increased significantly (80 mmHg, 143 mmHg, and 147 mm Hg; p = .001). The change of 
PaO2 by changing the I:E ratio was 49 % in PLV and 14 % in GV (p = .003). Lim et al 
concluded that increasing the I:E ratio by adding pause enhanced gas exchange in partial liquid 
ventilation. The researchers also concluded that the I:E ratio had a greater effect in the 
oxygenation of partial liquid ventilation than in gas ventilation. This article is related to the 
present study via the I:E ratios 1:2 and 2:1.  
 After reviewing the literature, tracheostomy tubes have important benefits in improving 
weaning success. Aerosol therapy can be easily inhaled through a tracheostomy tube if the 
proper interface is used. When inhaling antibiotic drugs via nebulizers, the drug levels in 
pulmonary secretions exceed by several doses when compared to the levels expected with 
intravenous administrations. Albuterol delivery through the tracheostomy tube was affected by 
the patient's interface, delivery method, and bias gas flow. In delivering albuterol, the T-piece 
was more efficient than the tracheostomy mask, the pMDI with valved holding chamber was 
more efficient than the nebulizer and the pMDI was more efficient in delivering albuterol when a 
T-piece was placed close to the spacer device than when placed in the distal position. Moreover, 
I:E ratio and pressure wave combination helped optimize oxygenation, ventilation, and mean 
airway pressure. The I:E ratio had a greater effect in the oxygenation of partial liquid ventilation 
than in gas ventilation. 
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CHAPTER III 
METHODS 
 This is in vitro study. It consisted of three main interfaces, the tracheostomy collar, the 
Wright mask and aerosol mask. In all interfaces, two I:E ratios of 1:2 and 2:1 were used. The 
tracheostomy collar was tested with both opened and closed fenestration of the tracheostomy 
tube. This chapter explained the methodology used to answer the following questions:   
1. What is the amount of albuterol delivered to the lungs with different interfaces using an 
open fenestration hole of the tracheostomy tube? 
2. How much albuterol is delivered using a tracheostomy collar, while the fenestration hole 
is opened and closed?  
3. What is the effect of I:E ratio on aerosol delivery in simulated spontaneously breathing 
adults with tracheostomy? 
Experimental Setup 
 As shown in Figure 1 a teaching mannequin (Medical Plastic Labs, Gatesville, TX) with 
a tracheostomy opening was used. Two of the mannequin's bronchi were connected to a "Y" 
adaptor, which was attached to a collecting filter (Respirgard 
™
 II 303, Vital Signs, Englewood, 
CO), which was connected to an inhalation port of a breathing simulator (Harvard Apparatus 
Dual Phase Control Respirator Pump, Holliston, MA) through a corrugated tube. 
 The breathing parameters of this study included f 20/min, and Vt 400 mL (Piccuito & 
Hess, 2005). The I:E ratios were adjusted in the first and second comparisons at 2:1 and 1:2, 
respectively. The nebulizer was operated by a flow meter (Timemeter, St. Louis, MO) at 8 L/min 
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with 100% oxygen. In every condition, the flow was discontinued at the end of nebulization. The 
jet nebulizer was attached to the tracheostomy collar in the first group, the Wright mask in the 
second group, and the aerosol mask in the third group.  
 
Figure 1. The experimental setup of the study. 
Interfaces 
As shown in Figure 2, the interfaces used in this study included a tracheostomy collar 
(AirLife
™
, Cardinal Health, McGaw Park, IL), a Wright mask (Wright Solutions LLC, 
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Marathon, FL), and an aerosol mask (AirLife
™
, Cardinal Health, McGaw Park, IL). A adult 
fenestrated tracheostomy tube (Shiley™, Mallinckrodt Medical Inc, Boulder, CO), size 8 mm, 
was placed into the mannequin's stoma. The cuff was always deflated. Each interface was tested 
in triplicate (n = 3), using I:E ratios of 1:2 and 2:1.  
 
Figure 2. The different interfaces of the study: (A) Wright mask, (B) Tracheostomy collar, and 
(C) Aerosol mask. 
Data Collection 
 While the Wright mask and the aerosol mask were tested with an opened fenestration 
hole, the tracheostomy collar was tested with the fenestration hole opened and closed. Each 
interface was tested in triplicate (n=3). A jet nebulizer (eValueMed, Tri-anim, Sylmar, CA) 
aerosolized 2.5 mg / 3 mL of albuterol sulfate (Dey Pharma Inc, Napa, CA) in each experiment. 
After eluting the collecting filter with 0.1% HCl, the filter was shaken for 3 minutes to ensure 
proper mixing. The absorption of the solution washed from the filter was measured with a 
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spectrophotometer (DC Series 500, Beckman Instruments, Fullerton, CA) at a wavelength of 276 
nm using a 1-mL quartz cuvette. A total of 24 experiments were conducted and the same 
protocol was followed for each experiment. The testing system was checked for correct interface, 
I:E ratio, and condition of the fenestration hole before testing.  
Data Analysis 
 The amount of aerosol deposited on the filter was quantified as a percentage of the 
emitted dose. The descriptive statistics including the mean and standard deviations were 
calculated for each condition tested in this study. Paired t-tests were conducted to evaluate 
differences in the mean inhaled presence of dose delivered by the jet nebulizer between two I:E 
ratios. One-Way Analysis of Variance (ANOVA) and Scheffe post-hoc multiple comparison 
were utilized to determine differences among the means for tracheostomy collar, Wright mask, 
and aerosol mask. Repeated measure ANOVA and Pairwise comparison were utilized to 
determine differences among the means between two fenestration holes. All data analysis was 
prepared using predictive analysis software (PASW, version 18.0), and statistical significance 
was defined as p < .05. 
 The research methods were directed by the study questions; what is the amount of 
albuterol delivered to the lungs with different interfaces using an open fenestration hole of the 
tracheostomy tube? how much albuterol is delivered using a tracheostomy collar, while the 
fenestration hole is opened and closed? and what is the effect of I:E ratio on aerosol delivery in 
simulated spontaneously breathing adults with tracheostomy? Three different interfaces, 
tracheostomy collar, Wright mask and aerosol mask were used. A Harvard Dual breathing 
simulator was used. The PASW, version 18.0 helped to control data analysis.  
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CHAPTER IV 
RESULTS 
 This study compared tracheostomy collar, Wright mask, and aerosol mask with one 
another to quantify the amount of aerosol delivery to a patient with tracheostomy receiving those 
types of interfaces. Differences were considered statistically significant when p < .05. The 
questions that were answered in this section include the following: 
 What is the amount of albuterol delivered to the lung with different interfaces using 
an opened fenestration hole of the tracheostomy tube? 
With an open fenestration hole the amounts of albuterol delivered to the lung with tracheostomy 
collar, Wright mask, and aerosol mask with 1:2 ratio were 6.98 ± .80 %, 4.08 ± .56 %, and 3.46 ± 
.04 %, respectively. The amounts of albuterol delivered to the lung with tracheostomy collar, 
Wright mask, and aerosol mask with 2:1 ratio were 11.57 ± 1.38 %, 7.15 ± .55 %, and 6.11 ± .46 
%, respectively. There was a significant statistical difference between groups (p = .001). As 
shown in Figure 3 the highest deposition was with the tracheostomy collar, while the lowest 
deposition was with the aerosol mask. 
 How much albuterol is delivered using a tracheostomy collar, while the fenestration 
hole is opened or closed? 
The results of opened fenestration were answered in the previous question. The amount of 
albuterol delivered while fenestration closed with 1:2 ratio was 9.37 ± 1.45 % compared to 12.44 
± 1.38 % with 2:1 ratio. There was a significant statistical difference between the fenestration 
closed with 2:1 ratio vs. fenestration opened with 1:2 ratio (p = .04). As shown in Figure 3 the 
deposition was higher with closed fenestration. 
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 What is the effect of I:E ratio on aerosol delivery in simulated spontaneously 
breathing adults with tracheostomy? 
In all groups, the total deposition was higher with 2:1 ratio 8.28 ± 2.63 % compared with 1:2 
ratio 4.84 ± 1.69 %. In all opened fenestration experiments, there were significant statistical 
differences between 1:2 ratio vs. 2:1 ratio (p < .05). However, with closed fenestration in the 
tracheostomy collar group there was no significant statistical difference between 1:2 vs. 2:1 
ratios (p = .18); see Figure 3. The longer the inspiratory time, the greater the amount of aerosol 
deposition.  
 
Figure 3. Inhaled mass percents among different interfaces at 1:2 and 2:1 ratios. (*) denotes p < 
.05. 
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In all cases, aerosol delivery was greater with the tracheostomy collar than the Wright 
mask and aerosol mask (p < .05). Closing the fenestration hole with the tracheostomy collar 
increased aerosol deposition significantly at 2:1 ratio compared to opening the fenestration hole 
with 1:2 ratio (p = .04). I:E ratio and aerosol delivery were directly related. Increasing I:E ratio 
from 1:2 to 2:1 improved aerosol delivery significantly in all opened fenestration experiments (p 
< .05).  
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CHAPTER V 
DISCUSSION 
The main purpose of this study was to investigate aerosol delivery with the Wright mask 
and compare it to aerosol delivery with the tracheostomy collar and aerosol mask at different I:E 
ratios. As answering the research questions: What is the amount of albuterol delivered to the 
lungs with different interfaces using an open fenestration hole of the tracheostomy tube? How 
much albuterol is delivered using a tracheostomy collar, while the fenestration hole is opened 
and closed? What is the effect of I:E ratio on aerosol delivery in simulated spontaneously 
breathing adults with tracheostomy? The study revealed that there is a significant amount of 
aerosol deposition when using jet nebulizer with tracheostomy collar when compared to the 
Wright mask and aerosol mask. The following discussion will look more closely at observations 
noted during the study and how this study was compared with the literature. It will also look at 
the clinical implications of the study, limitations of this study, and future studies needed. 
OBSERVATIONS 
Interfaces.  
 The results show greater delivery via tracheostomy collar than with the Wright mask and 
aerosol mask. The amount of albuterol delivered was significantly lower with the aerosol mask 
and the Wright mask. This was presumably the result of aerosol wasted into the air and in the 
upper airways above the stoma. When using the Wright mask and aerosol mask, aerosol travels  
through the nose, mouth and extrathoracic airways, which causes part of the aerosol delivered to 
be deposited before it reaches the collecting filter, thus reducing the effectiveness of aerosol 
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delivered with the Wright mask and the aerosol mask. It was not surprising that more aerosol 
particles were delivered with the tracheostomy collar when compared to all other interfaces in 
this  study. It was observed that when the fenestration hole closed during the tracheostomy collar 
experiments, aerosol particles were forced to deposit in the lower airways. It was also observed 
that using a tracheostomy collar reduced the amount of drug wasted to the atmosphere. 
Moreover, using a tracheostomy collar caused aerosol particles to travel shorter distances to 
reach the collecting filter when compared to the Wright mask and the aerosol mask. In addition, 
it was observed that during the expiratory phase there were more aerosol particles  exiting from 
the tracheostomy compared to the mouth and nose.  
 The Wright mask interface deposition results were lower than the tracheostomy collar 
interface deposition results. The initial expectation was that there would be greater deposition, 
especially when compared to the tracheostomy collar and aerosol mask interfaces. This was 
because the Wright mask has both a tracheostomy collar and an aerosol mask integrated in its 
design. Carvalho et al. (2010) evaluated the feasibility of the Wright mask and its efficacy with 
humidity. They concluded that there were no big differences noted in blood oxygen saturation, 
comfort, ease of use, or ease of breathing with the Wright mask compared to the tracheostomy 
collar and aerosol mask. 
 The result of the tracheostomy collar and fenestration closed at 1:2 ratio 9.37 ± 1.45 % is 
different than the result by Piccito and Hess (2005) when they compared tracheostomy collar vs. 
T-piece useing a non fenestrated tracheostomy tube at 1:2 ratio 12.9 ± 1.3 %. The diffrence 
between the results of the two studies stems from the fact that the experimental models were 
different. In addition, in this study, the cuff was deflated at all times allowing some aerosol  
particles to deposit in the upper airways. In addition, the Wright mask results indicated that there 
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were no big differences in aerosol depositions compared to the aerosol mask. It was also 
indicated that the Wright mask was less efficient compared to the tracheostomy collar. 
Therefore, the  results of this study matches the results presented by Carvalho et al (2010). 
Carvalho and his colleagues indicated that the Wright mask did not have a big difference in the 
efficiency and feasibility when compared to the tracheostomy collar and aerosol mask. 
I:E ratios.  
 The I:E ratio of 2:1 lead to more aerosol deposition in this study than that for 1:2. The 
difference in the amount of deposition between these I:E ratios can be explained by the breathing 
pattern and the respiratory phase in which the medication was delivered. With I:E ratio of 2:1, 
the inspiratory time is longer than it is with 1:2, which allows for more time to inhale the 
aerosolized drug, thus, causing more aerosol deposition in the lungs. In all fenestrated opened 
experiments, the amount of aerosolized albuterol deposition was affected significantly by the I:E 
ratio. These results matched the results by Lim et al. (1999) which indicate that increasing the I:E 
ratio by adding pause improved gas exchange in PLV. Oxygenation in PLV was affected by the 
I:E ratio to a greater degree than in gas ventilation.  
 Fenestration Hole.  
 In this study, aerosol deposition obtained from the tracheostomy tube while the 
fenestration closed was larger when compared to the open fenestration hole. The difference in 
the amount of deposition between fenestration opened and fenestration closed can be explained 
by the fact that aerosol was forced to go toward the collecting filter when the fenestration hole 
was closed. However, when the fenestration hole was opened some of the aerosol was leaking 
out of the hole and deposited up into the mouth and nose. This indicates that the pathway through 
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which medication was delivered affected the amount of aerosolized albuterol deposited 
significantly. This was confirmed by comparing the amount of aerosol deposition between 
fenestration closed with 2:1 ratio vs. fenestration opened with 1:2 ratio. The amount of aerosol 
deposited was greater with closed fenestration as compared to opened fenestration. This confirms 
that whether opened or closed the fenestration hole has a major impact on the aerosol deposition 
for the reasons mentioned earlier. This fact makes it logical that delivering aerosol therapy via 
tracheostomy collar will have the most aerosol deposition, which was the case in this study. 
During the expiration phase, it was noticed that aerosol was exiting from the stoma. Aerosol 
therapy administration  using a tracheostomy collar with an I:E ratio of 2:1 and closed 
fenestration hole had the  highest results, showing a greater delivery via tracheostomy collar than 
with the Wright mask and aerosol mask.  
  The anatomic dead space of a tracheostomy tube ID 7.5 mm is between 5 and 6 mL 
(Pierson, 2005). One study in cadavers determined the anatomic dead space of the extrathoracic 
airways (not including the trachea and main bronchi) to be roughly 75 mL (Nunn, Campbell, & 
Peckett, 1959). This is more than the dead space measured with tracheostomy tubes. Therefore, a 
tracheostomy tube reduces anatomic dead space. Thus, the amount of aerosol therapy delivered 
via tracheostomy collar is expected to be greater when compared with the Wright mask and the 
aerosol mask due to the reduced dead space. A review by Epstein (2005) stated that 
tracheostomy tubes can decrease dead space by 100 mL, when compared to a spontaneously 
breathing patient. In addition, when the fenestration hole is closed, aerosol mists are forced to go 
to the lungs; thus they will not be lost in the extrathoracic dead space including the nose and 
mouth. The previous discussion proves that among the three interfaces investigated in this study, 
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aerosol delivery with a tracheostomy collar with an I;E ratio of 2:1and closed fenestration had 
the highest aerosol deposition in the filter. 
Clinical Implications 
 Based on this study, three important recommendations can be given to clinicians to 
achieve a better outcome when administering aerosolized Medications. First, use a tracheostomy 
collar whenever is possible to administering aerosolized medications. Second, close the 
fenestration hole during aerosol administration. Third, instruct the patient to inhale the 
aerosolized medication slowly and instruct them to hold their breath for seconds after inspiration. 
Limitations 
 Because this experiment was an in vitro bench study, the results should be subjected to 
clinical validation. Different patients' breathing patterns may be seen in vivo. In addition, a 
homogenous breathing simulator was used. Human test subjects would show heterogeneous 
breathing patterns and different lung conditions. This investigation did not study the effect of 
different breathing patterns. The parameters were the same in all experiments. This study was 
conducted on only one type and size of tracheostomy tube.  
Future Studies 
 The effect of changing the respiratory setting should be explored to determine how 
aerosol delivery would be affected in different patients’ conditions, different diseases, and 
different ventilatory managements. Different I:E ratios should be explored further to help 
patients in relieving their symptoms and to provide guidance to clinicians on how to administer 
aerosol therapy. In addition, different types and sizes of tracheostomy tubes should be studied in 
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order to help other patients with different sizes or different types of tracheostomy tubes such as 
pediatrics tracheostomy tubes. 
Conclusion 
This study indicates that the use of a tracheostomy collar is the best method of delivering aerosol 
therapy when compared with the Wright mask and aerosol mask. The I:E ratio of 2:1 caused 
greater aerosol deposition when compared to I:E ratio of 1:2. The aerosol deposition was better 
when the fenestration hole was closed compared with opened fenestration using the 
tracheostomy collar.  
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